Asia Pacific CRISPR Gene Editing market will grow by 28.6% annually with a total addressable market cap of $21.45 billion over 2022-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.
Highlighted with 35 tables and 53 figures, this 126-page report “Asia Pacific CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country.
Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• CRISPR Products
o Kits & Enzymes
Vector-Based Cas9
DNA-Free Cas9
o Databases & Libraries
o Design Tools
o Antibodies
o CRISPR Plasmid & Vector
o Other Products
• CRISPR Services
o gRNA Design & Vector Construction
o Cell Line Engineering
o Microbial Gene Editing
o DNA Synthesis
o Other Services
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biomedical Research & Therapy
o Gene Therapy
o Drug Discovery
o Diagnostics
o Other Biomedical Applications
• Agriculture
• Industrial Use
• Other Applications
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutions & Research Centers
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 36
2.4 Emerging Opportunities and Market Trends 39
2.5 Porter’s Fiver Forces Analysis 43
3 Segmentation of Asia Pacific Market by Offering 47
3.1 Market Overview by Offering 47
3.2 CRISPR Products 49
3.2.1 Kits & Enzymes 51
3.2.2 Databases & Libraries 52
3.2.3 Design Tools 53
3.2.4 Antibodies 54
3.2.5 CRISPR Plasmid & Vector 55
3.2.6 Other Products 56
3.3 CRISPR Services 57
3.3.1 gRNA Design & Vector Construction 59
3.3.2 Cell Line Engineering 60
3.3.3 Microbial Gene Editing 61
3.3.4 DNA Synthesis 62
3.3.5 Other Services 63
4 Segmentation of Asia Pacific Market by Application 64
4.1 Market Overview by Application 64
4.2 Biomedical Research & Therapy 66
4.2.1 Gene Therapy 68
4.2.2 Drug Discovery 69
4.2.3 Diagnostics 70
4.2.4 Other Biomedical Applications 71
4.3 Agriculture 72
4.4 Industrial Use 73
4.5 Other Applications 74
5 Segmentation of Asia Pacific Market by End User 75
5.1 Market Overview by End User 75
5.2 Pharmaceutical Companies 77
5.3 Biotechnology Companies 78
5.4 Academic Institutions & Research Centers 79
5.5 Other End Users 80
6 Asia-Pacific Market 2021-2031 by Country 81
6.1 Overview of Asia-Pacific Market 81
6.2 Japan 84
6.3 China 87
6.4 Australia 89
6.5 India 92
6.6 South Korea 94
6.7 Rest of APAC Region 96
7 Competitive Landscape 98
7.1 Overview of Key Vendors 98
7.2 New Product Launch, Partnership, Investment, and M&A 102
7.3 Company Profiles 103
Abcam, Inc. 103
Agilent Technologies, Inc. 105
Applied StemCell, Inc. 106
Caribou Biosciences, Inc. 107
Cellecta, Inc. 108
CRISPR Therapeutics AG 109
Editas Medicine, Inc. 110
GeneCopoeia, Inc. 111
GeneScript Biotech Corporation 112
Horizon Discovery Group PLC 113
Integrated DNA Technologies, Inc. 114
Intellia Therapeutics Inc. 115
Lonza Group Ltd. 116
Merck KGaA 117
New England Biolabs, Inc. 118
Origene Technologies, Inc. 119
Rockland Immunochemicals, Inc. 120
Synthego Corporation 121
System Biosciences LLC 122
Takara Bio, Inc. 123
Thermo Fisher Scientific, Inc. 124
ToolGen, Inc. 125
RELATED REPORTS 126
List of Tables:
Table 1. Snapshot of Asia Pacific CRISPR Gene Editing Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 24
Table 3. Developing Roadmap of CRISPR Technology 28
Table 4. Private and Public Companies Investment in CRISPR Technology 29
Table 5. Comparison of CRISPR with Other Gene Editing Technologies 32
Table 6. World Health Spending by Region, $ bn, 2013-2020 35
Table 7. Main Product Trends and Market Opportunities in Asia Pacific CRISPR Gene Editing Market 39
Table 8. Asia Pacific CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 47
Table 9. Asia Pacific CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn 50
Table 10. Asia Pacific CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn 51
Table 11. Asia Pacific CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn 58
Table 12. Asia Pacific CRISPR Gene Editing Market by Application, 2021-2031, $ mn 64
Table 13. Asia Pacific CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn 67
Table 14. Asia Pacific CRISPR Gene Editing Market by End User, 2021-2031, $ mn 75
Table 15. APAC CRISPR Gene Editing Market by Country, 2021-2031, $ mn 82
Table 16. Japan CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 86
Table 17. Japan CRISPR Gene Editing Market by Application, 2021-2031, $ mn 86
Table 18. Japan CRISPR Gene Editing Market by End User, 2021-2031, $ mn 86
Table 19. China CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 88
Table 20. China CRISPR Gene Editing Market by Application, 2021-2031, $ mn 88
Table 21. China CRISPR Gene Editing Market by End User, 2021-2031, $ mn 88
Table 22. Australia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 91
Table 23. Australia CRISPR Gene Editing Market by Application, 2021-2031, $ mn 91
Table 24. Australia CRISPR Gene Editing Market by End User, 2021-2031, $ mn 91
Table 25. India CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 93
Table 26. India CRISPR Gene Editing Market by Application, 2021-2031, $ mn 93
Table 27. India CRISPR Gene Editing Market by End User, 2021-2031, $ mn 93
Table 28. South Korea CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 95
Table 29. South Korea CRISPR Gene Editing Market by Application, 2021-2031, $ mn 95
Table 30. South Korea CRISPR Gene Editing Market by End User, 2021-2031, $ mn 95
Table 31. CRISPR Gene Editing Market in Rest of APAC by Country/Region, 2021-2031, $ mn 97
Table 32. Breakdown of World Market by Key Vendor, 2021, % 100
Table 33. Abcam, Inc.: Company Snapshot 103
Table 34. Abcam, Inc.: Business Segmentation 104
Table 35. Abcam, Inc.: Product Portfolio 104
